Related Experiment Videos

Benefits and pitfalls of cardiovascular medication in seniors

Hana Matejovska Kubesova1, Pavel Weber, Hana Meluzinova

  • 1Department of Internal Medicine, Geriatrics and Practical Medicine, Masaryk University Faculty of Medicine and Brno Faculty Hospital, Czech Republic. hkubes@med.muni.cz

Wiener Klinische Wochenschrift
|July 13, 2013
PubMed

Insights

This study reviews cardiovascular disease treatments for older adults, highlighting drug benefits and risks like hyperkalemia with ACE inhibitors and bleeding with antiplatelets. Careful consideration of side effects is crucial for effective elderly cardiovascular care.

Area of Science:

  • Geriatrics
  • Cardiology
  • Pharmacology

Background:

  • Cardiovascular diseases (CVDs) are a major health concern in older populations.
  • Elderly patients often have complex health profiles, increasing risks associated with medication use.

Purpose of the Study:

  • To analyze the current treatment landscape for cardiovascular diseases in elderly patients.
  • To detail the benefits and potential risks of commonly prescribed cardiovascular medications in older adults.

Main Methods:

  • Review of current therapeutic strategies for cardiovascular diseases in the elderly.
  • Separate discussion of drug classes including angiotensin-converting enzyme inhibitors, antiplatelets, anticoagulants, beta-blockers, calcium channel blockers, statins, diuretics, nitrates, and digoxin.
  • Emphasis on age-specific risks and side effects.

Main Results:

  • Angiotensin-converting enzyme inhibitors offer benefits for hypertension and heart failure but carry a risk of hyperkalemia.
  • Antiplatelets and anticoagulants are effective for prophylaxis but increase gastrointestinal bleeding risk.
  • Beta-blockers are highly beneficial for morbidity and mortality but can cause bradycardia, especially with concurrent medications.

Conclusions:

  • Optimizing cardiovascular disease treatment in the elderly requires balancing therapeutic benefits against specific risks.
  • A comprehensive understanding of drug side effects and overdose symptoms is essential for safe and effective management in older patients.
  • The article provides a valuable resource with a table of side effects for commonly used medications in this demographic.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...